home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Making the Right Investments in Biomedical Informatics for Drug Development and Healthcare

 
  March 19, 2010  
     
 
DIA, National Harbor, MD USA
Oct 13 2010 - Oct 14 2010


How Health Care Data can be Used to Expand the Evidence Base and Promote Cost-eff ective Health Outcomes

This is the age of opportunity for health care! There is now so much health care data available that when it is aggregated, analyzed, mined and visualized it can provide the information needed to enable evidence-based, cost-eff ective, better health care. Biomedical Informatics is the scientifi c discipline that optimizes the access to and use of biomedical and health care information for the benefit of public health. This conference is about Biomedical Informatics. It sets out to identify the critical questions of public health policy, drug discovery and development, health care delivery, and begins to address how biomedical informatics is fundamental to advances in these areas.

CRITICAL QUESTIONS INCLUDE:
1. How do we encourage participation in the clinical research enterprise? Is integrative biomedical informatics the key to maximizing the value of what is learned from clinical trials?
2. How do drugs in the same therapeutic class compare in terms of safety and eff ectiveness? What do we know about diff erences in comparative safety and eff ectiveness by patient subpopulations?
3. How much do we know about drug safety and eff ectiveness at the time of drug approval? How can analytics maximize continued learning post approval?
4. How quickly and accurately can we detect and understand new safety signals? What are the practical challenges of obtaining, integrating, and analyzing the necessary data?
5. What Risk Evaluation and Mitigation Strategies (REMS) would ensure that drug benefi ts outweigh risks while minimizing added health care costs and maintaining patient access?
6. Do key health care stakeholders have access to the right information, of the right quality, at the right time, to make the best-informed decisions?

Event Code:
10030

 

 
 
Organized by: DIA
Invited Speakers: Call contact
 
Deadline for Abstracts: Call contact
 
Registration:

EVENT INFORMATION
Contact Rachel Minnick, Program Developer, Phone +1.215.442.6131

Attendees may visit the tabletop exhibits during the event and receptions.
Contact Shannon Lewis, Exhibits Associate, Phone +1.215.442.6149
Fax +1.215.442.6199, email
Shannon.Lewis@diahome.org

E-mail: Rachel.Minnick@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.